The way that a lot of pharmaceutical companies got their knowledge was often from going to other countries and finding out about Indigenous knowledge and then coming back and testing that. So there's a famous case of Eli Lilly patenting a treatment...
How are issues of equity addressed in health care innovation and in particular the patent process? Shobita Parthasarathy, professor of public policy and director of the Science, Technology, and Public Policy program, addressed the question on...
As the COVID-19 pandemic rages on, vaccines have allowed some freedom from the virus. But, patents on the vaccines are preventing others around the world from receiving the life saving shot. In turn, the White House has received pressure to waive...
The COVID-19 pandemic has revealed policymaking biases that have ignored poor and marginalized communities, argues Ford school professor Shobita Parthasarathy. In a paper, Innovation Policy, Structural Inequality, and COVID-19, published in the...
Intellectual property, and patents, in particular, affect every level of society. Research interest in the area has expanded beyond just the legal community and now involves social scientists and humanists as well. In an article published on...
When it comes to the patent system, the U.S. and Europe are having very different conversations. As Professor Shobita Parthasarathy explains in her new book, Patent Politics, patents for biotechnology such as gene editing are approached from a...
Shobita Parthasarathy, professor of public policy at the Ford School, is keeping tabs on the upcoming International Summit on Human Gene Editing in Hong Kong. In her October 23, 2018 piece for Nature titled “Use the patent system to regulate gene...
Shobita Parthasarathy has called for serious patent system reforms in a July 31 article she authored in The Conversation. Such reforms, she said, could "include increasing opportunities for the public to participate in patent decision-making,...
Shobita Parthasarathy's book on the development and implications of gene testing and patenting has been re-released in paperback by The MIT Press.The book, Building Genetic Medicine: Breast Cancer, Technology and the Comparative Politics of Health...
Priti Krishtel is a 15-year veteran of the global access to medicines movement. In 2006, she co-founded I-MAK, a nonprofit that works to combat the rising cost of prescription drugs by re-imagining the patent system so that people can get the lifesaving medicine they need.
This one-day symposium aims to grapple with this growing controversy, and explore ways forward for patents and patent systems that maximizes the public interest and social justice. The day will end with a book talk and reception celebrating the publication of Shobita Parthasarathy’s Patent Politics: Life Forms, Markets, and the Public Interest in the United States and Europe (University of Chicago Press, 2017).
Shobita Parthasarathy discusses her new book, Patent Politics: Life Forms, Markets, and the Public Interest in the United States and Europe (University of Chicago Press, 2017), followed by discussion with Richard Hall, Professor of Political Science and Public Policy, University of Michigan, then audience Q&A.
Shobita Parthasarathy, Christopher Avery, Nathan Hedberg, Jessie Mannisto, Molly Maguire
Intellectual property (IP) is often unrecognized as a form of governance, but it shapes the development of technology in pivotal ways. Both the US and UK governments have recognized this in their discussions about the governance of geoengineering,...
Shobita Parthasarathy discusses her new book, Patent Politics: Life Forms, Markets, and the Public Interest in the United States and Europe, followed by discussion with Richard Hall, Professor of Political Science and Public Policy.
